Midodrine Hcl
Rank #338 of 500 drugs by total cost
Data: CMS Medicare Part D, 2023 (most current available) · Updated March 2026
$30.9M
Total Cost
383,390
Total Claims
$30.9M
Total Cost
14,209
Prescribers
$81
Cost per Claim
46,952
Beneficiaries
510,725
30-Day Fills
$2,176
Avg Cost/Provider
27
Avg Claims/Provider
Share of Medicare Part D Spending
0.01%
of total Medicare Part D spending
$30.9M of $275.65B
Top Prescribers by Cost
Top 10 prescribers of $30.9M total
Top Prescribers of Midodrine Hcl
| # | Provider | Specialty | Location | Claims | Cost |
|---|---|---|---|---|---|
| 1 | Blair Grubb | Cardiology | Toledo, OH | 169 | $49K |
| 2 | Terence Frinks | Family Practice | Tucker, GA | 427 | $39K |
| 3 | Iqbal Amin | Internal Medicine | Saint Louis, MO | 256 | $39K |
| 4 | Salim Hanna | Family Practice | Lima, OH | 318 | $38K |
| 5 | David Schleinkofer | Cardiac Surgery | Fort Wayne, IN | 163 | $34K |
| 6 | Rajesh Agarwal | Internal Medicine | Mayfield Heights, OH | 434 | $34K |
| 7 | Sudhendu Choubey | Cardiology | Radford, VA | 210 | $32K |
| 8 | Andrew Graf | Internal Medicine | Plymouth Meeting, PA | 539 | $30K |
| 9 | Srinath Tadakamalla | Family Practice | Harrisonville, MO | 351 | $29K |
| 10 | Zvi Batash | Internal Medicine | Rego Park, NY | 238 | $29K |
| 11 | Christopher Labonte | Internal Medicine | Town And Country, MO | 347 | $28K |
| 12 | Morgane Giesecke | Nurse Practitioner | Nashville, TN | 139 | $27K |
| 13 | Prakash Shah | Cardiology | Milwaukee, WI | 205 | $27K |
| 14 | Daniel Miller | Internal Medicine | Columbus, OH | 315 | $25K |
| 15 | Vivek Gupta | Internal Medicine | Chicago, IL | 318 | $25K |
Top prescribers ranked by total cost for this drug in 2023.
Related Drugs by Cost
| # | Drug | Total Cost | Claims |
|---|---|---|---|
| 335 | Lorazepam (Lorazepam) | $31.3M | 3,237,827 |
| 336 | Diphth,pertuss(Acell),tet Vac (Boostrix Tdap) | $31.2M | 466,555 |
| 337 | Tafamidis Meglumine (Vyndaqel) | $31.0M | 1,387 |
| 338 | Midodrine Hcl (Midodrine Hcl) | $30.9M | 383,390 |
| 339 | Sarilumab (Kevzara) | $30.5M | 6,822 |
| 340 | Dabrafenib Mesylate (Tafinlar) | $30.4M | 2,377 |
| 341 | Testosterone (Testosterone) | $30.4M | 131,549 |
Related Analysis
Data from CMS Medicare Part D Prescriber-Drug Public Use File, 2023. Methodology